ConductScience.org, home

Paper36034693

Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont.

Kopelyanskiy D and 11 others. Front Cell Infect Microbiol, 2022. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont. Papers, record 36034693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36034693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont.
PubMed
Journal
Front Cell Infect Microbiol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2025-10-31
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kopelyanskiy DDmitry
2Desponds CChantal
3Prevel FFlorence
4Rossi MMatteo
5Migliorini RRomain
6Snäkä TTiia
7Eren RORemzi Onur
8Claudinot SStéphanie
9Lye LFLon-Fye
10Pasparakis MManolis
11Beverley SMStephen M
12Fasel NNicolas

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LeishmaniaMajor topic
Leishmania guyanensisMajor topic
Nitric Oxide Synthase Type IIMajor topic
Animals
Cytokines
Humans
Interleukin-17
Leishmaniavirus
Mice
NF-kappa B
Nitric Oxide
Toll-Like Receptor 3

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI029646NIAID NIH HHSUnited StatesR01AI029646PubMed and NIHNIH RePORTER
R01 AI031078NIAID NIH HHSUnited StatesR01AI031078PubMedNIH RePORTER
R01 AI130222NIAID NIH HHSUnited StatesR01AI130222PubMed and NIHNIH RePORTER

Download CSV of grants

References85

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129290574Gut Microbes Egested during Bites of Infected Sand Flies Augment Severity of Leishmaniasis via Inflammasome-Derived IL-1β.Cell Host Microbe2018https://conductscience.org/library/papers/29290574PubMed
27508336Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells.Cancer Res1994https://conductscience.org/library/papers/7508336PubMed
325605792limma powers differential expression analyses for RNA-sequencing and microarray studies.Nucleic Acids Res2015https://conductscience.org/library/papers/25605792PubMed
428930616Development of a semi-automated image-based high-throughput drug screening system.Front Biosci (Elite Ed)2018https://conductscience.org/library/papers/28930616PubMed
524954794The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.Trends Parasitol2014https://conductscience.org/library/papers/24954794PubMed
621747391Leishmaniasis: complexity at the host-pathogen interface.Nat Rev Microbiol2011https://conductscience.org/library/papers/21747391PubMed
723415155Mechanisms of immune evasion in leishmaniasis.Adv Appl Microbiol2013https://conductscience.org/library/papers/23415155PubMed
829487860Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β.Microb Cell2018https://conductscience.org/library/papers/29487860PubMed
912415308The immunology of susceptibility and resistance to Leishmania major in mice.Nat Rev Immunol2002https://conductscience.org/library/papers/12415308PubMed
1031727782The role of interleukin-17 in tumor development and progression.J Exp Med2020https://conductscience.org/library/papers/31727782PubMed
1119008218A20: central gatekeeper in inflammation and immunity.J Biol Chem2009https://conductscience.org/library/papers/19008218PubMed
1219364834Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice.Infect Immun2009https://conductscience.org/library/papers/19364834PubMed
1324801628MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden.PLoS One2014https://conductscience.org/library/papers/24801628PubMed
1417072323Transcriptional regulation via the NF-kappaB signaling module.Oncogene2006https://conductscience.org/library/papers/17072323PubMed
1522685311Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.J Immunol2012https://conductscience.org/library/papers/22685311PubMed
161620160Transcribing and replicating particles in a double-stranded RNA virus from Leishmania.Mol Biochem Parasitol1992https://conductscience.org/library/papers/1620160PubMed
1720438856Regulation of the expression of inducible nitric oxide synthase.Nitric Oxide2010https://conductscience.org/library/papers/20438856PubMed
183200841LR1: a candidate RNA virus of Leishmania.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3200841PubMed
1922302935NF-κB, the first quarter-century: remarkable progress and outstanding questions.Genes Dev2012https://conductscience.org/library/papers/22302935PubMed
2016178423Identification of the +1 ribosomal frameshifting site of LRV1-4 by mutational analysis.Arch Pharm Res2005https://conductscience.org/library/papers/16178423PubMed

See all 85 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41286466Comparative histopathological and immunological analysis of LRV2-positive and LRV2-negative Leishmania tropica in a BALB/c mouse cutaneous leishmaniasis model.Parasitol Res2025https://conductscience.org/library/papers/41286466PubMed
39065086Epidemiology and Genetic Characterization of Leishmania RNA Virus in Leishmania (Viannia) spp. Isolates from Cutaneous Leishmaniasis Endemic Areas in Panama.Microorganisms2024https://conductscience.org/library/papers/39065086PubMed
39058005Microbial Matryoshka: Addressing the Relationship between Pathogenic Flagellated Protozoans and Their RNA Viral Endosymbionts (Family Totiviridae).Vet Sci2024https://conductscience.org/library/papers/39058005PubMed
36588414Leishmania Vaccines: the Current Situation with Its Promising Aspect for the Future.Korean J Parasitol2022https://conductscience.org/library/papers/36588414PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36034693

GET https://conductscience.org/api/papers/v1/36034693/references?page=2